Objective-To assess attitudes to the use of thromboprophylaxis among orthopaedic surgeons in the United Kingdom.
Introduction
Deep venous thrombosis and its sequel, pulmonary embolism, are major problems in orthopaedic surgery.
The incidence of thrombosis after arthroplasty of the hip and knee exceeds 50% in many studies' and it is a feared though less widely recognised complication of lower limb fractures. Even apparently benign procedures such as fixation of ankle fractures and diagnostic arthroscopy of the knee have resulted in fatal pulmonary embolism.5 '6 Many prophylactic agents such as heparin, warfarin, and dextran are reported to be less effective in orthopaedic practice than in other forms of surgery.34 In addition, the possibility of inducing bleeding, which may lead to wound haematoma, infection, and implant failure, is perceived as an unacceptable risk by some surgeons. (2) 18 (3) A recent article suggested that prophylactic drugs were given routinely by less than half of all British orthopaedic surgeons who carry out total hip replacement, and it concluded that they were not convinced of the value of using antithrombotic prophylaxis.7 We considered that this conclusion was mistaken and determined to investigate more fully. Method A questionnaire on a single A4 size sheet was sent to 926 active orthopaedic surgeons who are members of the British Orthopaedic Association. They were asked whether or not they used prophylaxis. Those who answered no were asked to reply to a supplementary question about their reasons for not doing so. Those who answered yes were asked for more details about the nature, timing, duration, and indications for the use ofprophylaxis and for their assessment of the major risk factors for thromboembolism. All were invited to comment on the reverse of the form if they wished.
Results
Replies were received from 659 surgeons (70%). Over 90% of these (595) said that they used prophylaxis against deep venous thrombosis, 548 (83%) using a drug and only 47 relying solely on elasticated stockings. Table I gives details of the use of mechanical methods of prophylaxis with and without drugs. Table II shows the use of drugs. Many surgeons used more than one drug, either in combination or for different patients depending on their assessment of risk factors.
With regard to timing of drug prophylaxis, 349 (58%) started before operation, 153 (26%) during operation, and 93 (16%) afterwards. Prophylaxis was continued for a specific period by 265 (45%) and until the patient was mobile or discharged by 330 (55%). These regimens usually fell into patterns depending on the agents used-for example, subcutaneous heparin given preoperatively and continued for seven to 10 days or dextran started intraoperatively and given for two or three days.
The factors most frequently cited as contributing to a high risk state are presented in table III. The answers given reflect conventional wisdom. Although most of those mentioning age as a risk factor considered increasing age to give increased risk, 12 suggested the (2) reverse. This may reflect the dramatic impact that the sudden death of young patients has on the clinicians responsible for their care. Among those not using prophylaxis, perceived lack of efficacy was the most widely quoted reason for not doing so (table IV) . Of those for whom deep venous thrombosis was "not a problem" about half had practices confined largely to hand surgery or paediatric surgery. Organisational problems reported included a shortage of junior medical or nursing staff to supervise prophylactic regimens.
Discussion
The results ofthis survey show that venous thromboembolism is regarded as a frequent and sinister complication of orthopaedic surgery, and that most orthopaedic surgeons take active steps to try to prevent its occurrence. The variety of techniques and drugs used reflects the conflicting evidence available in the many reports on this subject. As might be expected, low dose heparin is the most popular regimen as it is the most convenient to administer and requires no laboratory monitoring. It seems effective in reducing the incidence of calf thrombosis but may not be effective against proximal segment deep venous thrombosis89 and subsequent pulmonary embolism. The new low molecular weight heparins given once daily will increase the acceptability of this method to nursing staff and patients, so may become even more widely used.'0 Warfarin is also commonly used, especially for those regarded as being at high risk. Most surgeons who use it do not start until after the operation and may thereby limit its effectiveness. Hydroxychloroquine (Plaquenil) given orally after total hip replacement was popularised by the late Sir John Charnley, but there is considerable doubt about -its efficacy." 12 Dextran is commonly used, especially for hip surgery, and seems to be effective in decreasing the incidence of pulmonary embolism in these circumstances. Problems with anaphylaxis seem to be much less common in the United Kingdom than in Europe. '3 Physical methods of prophylaxis are generally perceived as being safe to use'4 1 ' but of limited effectiveness in orthopaedic practice. None the less most orthopaedic surgeons use elasticated stockings. Relatively few use the more active methods of preventing venous stasis, although these may be increasing in popularity.
Despite evidence that the thrombotic risk persists for many weeks following surgery,'6 prophylaxis is usually stopped much earlier. We thank all the surgeons who responded to the questionnaire for their help and Rhone-Poulenc (UK) for financial assistance.
